Navigation Links
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
Date:9/18/2009

A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages(United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

Honolulu, HI (PRWEB) September 18, 2009 -- A federal jury in Tampa Florida returned a verdict in favor of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med's Horizontal Therapy patent and awarded damages (United States District Court, Middle District of Florida Case No.: 8:06-cv1790-T33AEP). In addition, the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 devices manufactured prior to November 28th 2006.

A day earlier a federal judge in the United States District Court, Middle District of Florida, Tampa division, the honorable Virginia M. Hernandez Covington, made a temporary injunction against Axiom Worldwide permanent thereby baring Axiom Worldwide from using one of Hako-Med's trademarks.

Axiom Worldwide, based in Tampa Florida, manufactures spinal decompression devices as well as a pain management device, which was found to infringe on Hako-Med's unique patented pain therapy. Axiom Worldwide's head-engineer further admitted under oath that Axiom had done no validation through published clinical studies on their EPS 8000 devices prior to marketing the unsubstantiated claims to physicians that the EPS8000 devices "presents a breakthrough in electrical stimulation therapy" and "the most advanced Electrical Nerve stimulation available today."

Axiom Worldwide has additional pending litigation with other companies, including an alleged trademark infringement suit. (North American Medical vs. Axiom Worldwide No. 1:06-CV-1678-JTC)

Hako-Med offers a special amnesty period from civil litigations for any physician who wants to upgrade from an infringing device to Hako-Med Horizontal Therapy devices by the end of October 2009. (www.hakomed.com)

Hako-Med's policy is to vigorously defend its intellectual property portfolio. Hako-Med is the only manufacturer and supplier of devices with the patented Horizontal Therapy. Horizontal Therapy has been known through many clinical trials to outperform existing treatment methods in the treatment of pain from Osteoarthritis by having immediate as well as longer lasting therapeutic effects without any negative side effects.

For interviews please contact. Kai Hansjurgens president of Hako-Med USA at 1-888-913-7900 www.hakomed.com.

###

Read the full story at http://www.prweb.com/releases/Horizontal_Therapy/Patent_Infringement/prweb2905684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. AXIOM Selects Foresight Corp. for Integration Partnership
2. Axiom Named to Healthcare Informatics Top 100 List
3. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
7. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
8. Global Med Technologies(R) Extends Its Worldwide Outreach
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
11. New USAID grant helps Georgetown meet unmet family planning needs worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Axiom Worldwide Convicted of Infringing a Hako-Med Patent
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... NORFOLK, Va. (Dec. 3, 2016) , ... (PRWEB) ... ... the nation’s only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, ... work in New Mexico with a patient engagement program. New Mexico has more ...
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to reduce the effects ... water or limiting their exposure to the sun, according to a November 30 ... Hills Physicians (BHP) notes that, while preventive measures to help keep ourselves looking our ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... prescriptive health insights for population health management, announces today a strategic relationship ... leverage CitiusTech’s cloud-hosted clinical rules engine that offers advanced Clinical Quality Measures ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016  "Blood Tests replace Surgical ... ....." The Diagnostic, Monitoring and Screening Test ... diagnostics is occurring using in vitro blood testing ... with impressive backing, has announced a single blood ... moving faster than the market. New technology that ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
Breaking Medicine Technology: